Fortress Biotech Announces Exclusive Worldwide License Agreement With AstraZeneca and Cincinnati Children's Hospital Medical Center to Develop a Novel Treatment for Select CNS Disorders

Stock Information for Fortress Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.